Skip to content

Acute changes in metabolic parameters after bolus fluid treatment in critically ill patients

Evaluating the changes of cardiac output, oxygen and CO2 derived variables and lactate before and after bolus fluid treatment in critically ill patients with suspected hypovolemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN31590683
Enrollment
100
Registered
2016-06-30
Start date
2015-01-15
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically ill patients with suspected hypovolemia Haematological Disorders Hypovolemia

Interventions

Patients are included in the study if they needed to receive intravenous fluids consisting of 500 ml of colloids or 1000 ml of crystalloids within 30–50 minutes. The decision to administer bolus fluid

Sponsors

CHU-Brugmann
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient treated in ICU 2. Suspicion of hypovolemia that must be treated 3. Available central venous and arterial catheter 4. Available method for cardiac output measurment (thermodilution, doppler)

Exclusion criteria

Exclusion criteria: 1. Aged under 18 year 2. No jugular or subclavian venous catheter and arterial catheter 3. Individuals on whom it is not possible to measure cardiac output 4. Patients receiving extracorporeal membrane oxygenation (ECMO) support 5. Receipt of interventions (i.e. introduction or increase in the dose of inotropes, changes or introduction of mechanical ventilation) within 30 minutes prior to fluid administration

Design outcomes

Primary

MeasureTime frame
1. Oxygen consumption (VO2) is calculated using the formula arterial oxygen content-Venous oxygen content before and after bolus fluid treatment 2. Oxygen delivery (DO2) is calculated using the formula 10*CI* arterial oxygen content before and after bolus fluid treatment

Secondary

MeasureTime frame
No secondary outcome measures

Countries

Belgium

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026